| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $4.92M | - | |
| Other | 21.6K | $1.40M | - | |
| Other | 15.4K | $1.00M | -5,538 | |
| Dir | 8.0K | $518.7K | - | |
| Dir | 8.0K | $518.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 16, 2017 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 2,651 | $19.55 | $51,827.05 | -4.8% | |
| May 16, 2017 | Robin Howard W58 | President &CEO | Sell | 8,388 | $19.55 | $163,985.40 | -5.0% | |
| May 16, 2017 | Nicholson John | SVP &Chief Operating Officer | Sell | 3,146 | $19.55 | $61,504.30 | -1.7% | |
| May 16, 2017 | Labrucherie Gil M84 | SVP &Chief Financial Officer | Sell | 3,179 | $19.55 | $62,149.45 | -4.6% | |
| May 16, 2017 | Hora Maninder | SVP Pharma Dev &Mfg Ops | Sell | 2,959 | $19.55 | $57,848.45 | -4.6% | |
| May 16, 2017 | Gergel Ivan P. | SVP &Chief Medical Officer | Sell | 1,450 | $19.55 | $28,347.50 | -3.2% | |
| May 16, 2017 | Doberstein Stephen K | SVP &Chief Scientific Officer | Sell | 1,701 | $19.55 | $33,254.55 | -4.9% | |
| May 15, 2017 | Chess Robert84 | Director | Sale+OE | 5,000 | $19.79 | $98,950.00 | -1.8% | |
| Apr 17, 2017 | Chess Robert84 | Director | Sale+OE | 5,000 | $18.72 | $93,600.00 | -1.8% | |
| Apr 7, 2017 | Lingnau Lutz | Director | Sell | 7,000 | $20.05 | $140,350.00 | -23.0% |